Jean‐Léon Lagrange

Author

Jean‐Léon Lagrange

Also Known As

J L Lagrange, J LAGRANGE, J. L. LAGRANGE, J. L. Lagrange, J. Lagrange, J.-L. Lagrange, J.L Lagrange, J.L. Lagrange, Jean Leon Lagrange, Jean-Leon Lagrange

111

Publications

4.9K

Citations

H-Index

Concepts

All Affiliations

Centre Antoine Lacassagne Inserm Centre Léon Bérard Institut Gustave Roussy Hôpitaux Universitaires Henri-Mondor

About

Jean‐Léon Lagrange is an author at Centre Antoine Lacassagne specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	34	3K
2	Health Sciences	10	10	485
3	Public Health	3	3	152
4	Engineering	1	1	10
5	Natural Sciences	1	1	12

Jean‐Léon Lagrange

Publications

4.5K

Citations

H-Index

Page 1

	Year	Citations
70 Gy Versus 80 Gy in Localized Prostate Cancer: 5-Year Results of GETUG 06 Randomized Trial V. Beckendorf, S. Guérif, É. Le Prisé, International Journal of Radiation OncologyBiologyPhysics UrologySurgical OncologyGenitourinary CancerMedicineCancer Management	2010	447
Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial C. Carrié, Ali Hasbini, Guy de Laroche, The Lancet Oncology UrologySurgical OncologySalvage RadiotherapyRadiation TherapyMedicine	2016	356
Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial C. Carrié, Nicolas Magné, Patricia Burban-Provost, The Lancet Oncology Surgical OncologyUrologyRadiation TherapyGenitourinary CancerMedicine	2019	239
Androgen deprivation therapy plus docetaxel and estramustine versus androgen deprivation therapy alone for high-risk localised prostate cancer (GETUG 12): a phase 3 randomised controlled trial Karim Fizazi, Laura Faivre, F. Lesaunier, The Lancet Oncology UrologyGetug 12Genitourinary CancerMedicineAndrogen Deprivation Therapy	2015	236
Sarcoma after Radiation Therapy: Retrospective Multiinstitutional Study of 80 Histologically Confirmed Cases Jean‐Léon Lagrange, A. Ramaioli, Marie‐Christine Chateau, Radiology	2000	202
Radiation dose, chemotherapy and risk of osteosarcoma after solid tumours during childhood Béatrice Le Vu, Florent de Vathaire, Akhtar Shamsaldin, International Journal of Cancer	1998	190
Is There a Role for Pelvic Irradiation in Localized Prostate Adenocarcinoma? Update of the Long-Term Survival Results of the GETUG-01 Randomized Study P. Pommier, Sylvie Chabaud, Jean‐Léon Lagrange, International Journal of Radiation OncologyBiologyPhysics Surgical OncologyUrologyRadiation TherapyMedicineGetug-01 Randomized Study	2016	162
Common Strategy for Adult and Pediatric Medulloblastoma: A Multicenter Series of 253 Adults Laëtitia Padovani, Marie‐Pierre Sunyach, David Pérol, International Journal of Radiation OncologyBiologyPhysics Neuro-oncologyPediatric Brain TumorsPediatric NeurosurgerySurgical PathologyCommon Strategy	2007	157
Impact of targeting deviations on outcome in medulloblastoma: study of the French society of pediatric oncology (SFOP)11Participating institutions including more than one patient: Centre Paul Papin—Angers (M. Mege); Bruxelles (C. De Vriendt); Centre Claudius Regaud—Toulouse (F. Soum); Hôpital Charles Nicolle—Rouen (S. Seng); Institut Jean Godinot—Reims (X. Panis); Hôpital Bellevue—Saint-Etienne (T. Schmitt). C. Carrié, S. Hoffstetter, F. Gómez, International Journal of Radiation OncologyBiologyPhysics Neuro-oncologyPediatric Brain TumorsPediatric NeurosurgeryMedicineCancer Management	1999	154
Malignant Breast Tumors After Radiotherapy for a First Cancer During Childhood Catherine Guibout, Élisabeth Adjadj, Carolé Rubino, Journal of Clinical Oncology	2004	142

Page 1